Vistagen Therapeutics

10.05.2016 | NASDAQ

The firm represented the investment bank Chardan Capital Markets as an underwriter in a public offering of $10 million

Attorneys Oded Har-Even, Rob Condon and Hila Nahum represented the Bank on a public offering of VistaGen Therapeutics, a biomed company that develops products for the treatment of diseases related to the nervous system.


Recent Activity